Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.
The molecular interaction of fibroblast growth factor 23 (FGF23) and klotho is essential for physiologic regulation of phosphate balance. In the absence of klotho, the FGF23 protein cannot exert its physiologic functions, as demonstrated by in vivo mouse genetic studies. Bioactive FGF23 protein loses its phosphate lowering effects in genetically modified mice with no klotho activity. The FGF23-klotho system not only affects phosphate homeostasis but can also influence parathyroid hormone (PTH) and vitamin D activities. Dysregulation of the FGF23-klotho system is noted in a number of human acquired and genetic diseases, including chronic kidney disease. Vitamin D is a strong inducer of both FGF23 and klotho expression, while FGF23 can suppress the renal expression of 1alpha(OH)ase to reduce 1,25(OH)(2)D activity. An understanding of the complex interactions of phosphate, vitamin D and PTH with the FGF23-klotho system has paved the way to explore the therapeutic benefits of modulating the FGF23-klotho system in diseases associated with abnormal mineral ion balance. The patent (WO2009095372) under discussion proposes using fusion polypeptides to manipulate the FGF23-klotho system.
Razzaque
Mohammed S
MS
Harvard School of Dental Medicine, Department of Oral Medicine, Infection and Immunity, 190 Longwood Avenue, Boston, MA 02115, USA. mrazzaque@hms.harvard.edu
D000818:Animals; D016503:Drug Delivery Systems; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D005966:Glucuronidase / Q000378:metabolism*; D006801:Humans; D000090265:Klotho Proteins; D051379:Mice; D010281:Parathyroid Hormone / Q000378:metabolism; D010330:Patents as Topic; D010455:Peptides / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D010710:Phosphates / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism
C000717427:FGF23 protein, human; C000717428:Fgf23 protein, mouse; D010281:Parathyroid Hormone; D010455:Peptides; D010710:Phosphates; D014807:Vitamin D; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D005966:Glucuronidase; D000090265:Klotho Proteins
Kidney Int. 2010 Mar;77(5):390-2
20150940
Biochem Biophys Res Commun. 2001 Feb 2;280(4):1015-20
11162628
J Endocrinol. 2007 Jul;194(1):1-10
17592015
J Am Soc Nephrol. 2007 Sep;18(9):2600-8
17656479
Kidney Int. 2009 Jun;75(11):1166-1172
19225558
Nat Genet. 2000 Nov;26(3):345-8
11062477
Biochem Biophys Res Commun. 2000 Oct 22;277(2):494-8
11032749
J Am Soc Nephrol. 2008 Dec;19(12):2342-50
18753255
Nat Rev Endocrinol. 2009 Nov;5(11):611-9
19844248
Nephrol Dial Transplant. 2009 Jan;24(1):4-7
18996835
Hum Mol Genet. 2005 Feb 1;14(3):385-90
15590700
J Cell Biol. 2008 Aug 11;182(3):459-65
18678710
J Clin Endocrinol Metab. 2010 Feb;95(2):578-85
19965919
Nat Clin Pract Endocrinol Metab. 2007 Dec;3(12):788-9
17925800
FASEB J. 2009 Nov;23(11):3702-11
19584304
FASEB J. 2009 Feb;23(2):433-41
18835926
FASEB J. 2006 Apr;20(6):720-2
16436465
Ageing Res Rev. 2007 May;6(1):73-9
17353153
Cytokine Growth Factor Rev. 2005 Apr;16(2):107-37
15863029
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19796-801
18056631
J Biol Chem. 2006 Mar 10;281(10):6120-3
16436388
Am J Physiol Renal Physiol. 2009 Aug;297(2):F282-91
19515808
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):407-12
19966287
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6500-5
11344269
Circ Cardiovasc Genet. 2009 Dec;2(6):583-90
20031638
N Engl J Med. 2003 Apr 24;348(17):1656-63
12711740
Nature. 2006 Dec 7;444(7120):770-4
17086194
Trends Mol Med. 2006 Jul;12(7):298-305
16731043
Mol Cell Biol. 2007 May;27(9):3417-28
17339340
Curr Opin Nephrol Hypertens. 2006 Jul;15(4):437-41
16775459
Nature. 1997 Nov 6;390(6655):45-51
9363890
Curr Opin Nephrol Hypertens. 2007 Jul;16(4):311-8
17565272
Am J Physiol Renal Physiol. 2009 Mar;296(3):F470-6
19019915